-
2
-
-
33744944082
-
Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human
-
C. Bossen, K. Ingold, A. Tardivel, J.L. Bodmer, O. Gaide, S. Hertig, C. Ambrose, J. Tschopp, and P. Schneider Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human J. Biol. Chem. 281 2006 13964 13971
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 13964-13971
-
-
Bossen, C.1
Ingold, K.2
Tardivel, A.3
Bodmer, J.L.4
Gaide, O.5
Hertig, S.6
Ambrose, C.7
Tschopp, J.8
Schneider, P.9
-
3
-
-
0038708366
-
The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation
-
S.A. Brown, C.M. Richards, H.N. Hanscom, S.L. Feng, and J.A. Winkles The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation Biochem. J. 371 2003 395 403
-
(2003)
Biochem. J.
, vol.371
, pp. 395-403
-
-
Brown, S.A.1
Richards, C.M.2
Hanscom, H.N.3
Feng, S.L.4
Winkles, J.A.5
-
4
-
-
33746093941
-
TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules
-
S.A. Brown, H.N. Hanscom, H. Vu, S.A. Brew, and J.A. Winkles TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules Biochem. J. 397 2006 297 304
-
(2006)
Biochem. J.
, vol.397
, pp. 297-304
-
-
Brown, S.A.1
Hanscom, H.N.2
Vu, H.3
Brew, S.A.4
Winkles, J.A.5
-
5
-
-
80054865852
-
TWEAK/Fn14 pathway: An immunological switch for shaping tissue responses
-
L.C. Burkly, J.S. Michaelson, and T.S. Zheng TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses Immunol. Rev. 244 2011 99 114
-
(2011)
Immunol. Rev.
, vol.244
, pp. 99-114
-
-
Burkly, L.C.1
Michaelson, J.S.2
Zheng, T.S.3
-
6
-
-
24644506070
-
The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity
-
S. Campbell, J. Michaelson, L. Burkly, and C. Putterman The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity Front. Biosci. 9 2004 2273 2284
-
(2004)
Front. Biosci.
, vol.9
, pp. 2273-2284
-
-
Campbell, S.1
Michaelson, J.2
Burkly, L.3
Putterman, C.4
-
7
-
-
84901010269
-
Elevated expression of activins promotes muscle wasting and cachexia
-
J.L. Chen, K.L. Walton, C.E. Winbanks, K.T. Murphy, R.E. Thomson, Y. Makanji, H. Qian, G.S. Lynch, C.A. Harrison, and P. Gregorevic Elevated expression of activins promotes muscle wasting and cachexia FASEB J. 28 2014 1711 1723
-
(2014)
FASEB J.
, vol.28
, pp. 1711-1723
-
-
Chen, J.L.1
Walton, K.L.2
Winbanks, C.E.3
Murphy, K.T.4
Thomson, R.E.5
Makanji, Y.6
Qian, H.7
Lynch, G.S.8
Harrison, C.A.9
Gregorevic, P.10
-
8
-
-
74549220324
-
Antibodies to TWEAK receptor inhibit human tumor growth through dual mechanisms
-
P.A. Culp, D. Choi, Y. Zhang, J. Yin, P. Seto, S.E. Ybarra, M. Su, M. Sho, R. Steinle, M.H. Wong, and et al. Antibodies to TWEAK receptor inhibit human tumor growth through dual mechanisms Clin. Cancer Res. 16 2010 497 508
-
(2010)
Clin. Cancer Res.
, vol.16
, pp. 497-508
-
-
Culp, P.A.1
Choi, D.2
Zhang, Y.3
Yin, J.4
Seto, P.5
Ybarra, S.E.6
Su, M.7
Sho, M.8
Steinle, R.9
Wong, M.H.10
-
9
-
-
0018949428
-
Prognostic effect of weight loss prior to chemotherapy in cancer patients
-
W.D. Dewys, C. Begg, P.T. Lavin, P.R. Band, J.M. Bennett, J.R. Bertino, M.H. Cohen, H.O. Douglass Jr., P.F. Engstrom, E.Z. Ezdinli, et al. Eastern Cooperative Oncology Group Prognostic effect of weight loss prior to chemotherapy in cancer patients Am. J. Med. 69 1980 491 497
-
(1980)
Am. J. Med.
, vol.69
, pp. 491-497
-
-
Dewys, W.D.1
Begg, C.2
Lavin, P.T.3
Band, P.R.4
Bennett, J.M.5
Bertino, J.R.6
Cohen, M.H.7
Douglass, H.O.8
Engstrom, P.F.9
Ezdinli, E.Z.10
-
10
-
-
34249775509
-
TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine
-
C. Dogra, H. Changotra, N. Wedhas, X. Qin, J.E. Wergedal, and A. Kumar TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine FASEB J. 21 2007 1857 1869
-
(2007)
FASEB J.
, vol.21
, pp. 1857-1869
-
-
Dogra, C.1
Changotra, H.2
Wedhas, N.3
Qin, X.4
Wergedal, J.E.5
Kumar, A.6
-
11
-
-
33744542153
-
Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein
-
C. Dogra, H. Changotra, S. Mohan, and A. Kumar Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein J. Biol. Chem. 281 2006 10327 10336
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 10327-10336
-
-
Dogra, C.1
Changotra, H.2
Mohan, S.3
Kumar, A.4
-
12
-
-
0022891340
-
Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing
-
H.F. Dvorak Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing N. Engl. J. Med. 315 1986 1650 1659
-
(1986)
N. Engl. J. Med.
, vol.315
, pp. 1650-1659
-
-
Dvorak, H.F.1
-
13
-
-
0019739585
-
Preparation of monoclonal antibodies: Strategies and procedures
-
G. Galfrè, and C. Milstein Preparation of monoclonal antibodies: strategies and procedures Methods Enzymol. 73 Pt B 1981 3 46
-
(1981)
Methods Enzymol.
, vol.73
, pp. 3-46
-
-
Galfrè, G.1
Milstein, C.2
-
14
-
-
33845689427
-
TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration
-
M. Girgenrath, S. Weng, C.A. Kostek, B. Browning, M. Wang, S.A. Brown, J.A. Winkles, J.S. Michaelson, N. Allaire, P. Schneider, and et al. TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration EMBO J. 25 2006 5826 5839
-
(2006)
EMBO J.
, vol.25
, pp. 5826-5839
-
-
Girgenrath, M.1
Weng, S.2
Kostek, C.A.3
Browning, B.4
Wang, M.5
Brown, S.A.6
Winkles, J.A.7
Michaelson, J.S.8
Allaire, N.9
Schneider, P.10
-
15
-
-
0038242506
-
TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-kappa B through TNF receptor-associated factors
-
S. Han, K. Yoon, K. Lee, K. Kim, H. Jang, N.K. Lee, K. Hwang, and S. Young Lee TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-kappa B through TNF receptor-associated factors Biochem. Biophys. Res. Commun. 305 2003 789 796
-
(2003)
Biochem. Biophys. Res. Commun.
, vol.305
, pp. 789-796
-
-
Han, S.1
Yoon, K.2
Lee, K.3
Kim, K.4
Jang, H.5
Lee, N.K.6
Hwang, K.7
Young Lee, S.8
-
16
-
-
0035875178
-
Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradation
-
B.S. Islam-Ali, and M.J. Tisdale Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradation Br. J. Cancer 84 2001 1648 1655
-
(2001)
Br. J. Cancer
, vol.84
, pp. 1648-1655
-
-
Islam-Ali, B.S.1
Tisdale, M.J.2
-
17
-
-
33750350777
-
Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis
-
K. Kamata, S. Kamijo, A. Nakajima, A. Koyanagi, H. Kurosawa, H. Yagita, and K. Okumura Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis J. Immunol. 177 2006 6433 6439
-
(2006)
J. Immunol.
, vol.177
, pp. 6433-6439
-
-
Kamata, K.1
Kamijo, S.2
Nakajima, A.3
Koyanagi, A.4
Kurosawa, H.5
Yagita, H.6
Okumura, K.7
-
18
-
-
84869856705
-
Current pharmacotherapy options for cancer anorexia and cachexia
-
A. Macciò, C. Madeddu, and G. Mantovani Current pharmacotherapy options for cancer anorexia and cachexia Expert Opin. Pharmacother. 13 2012 2453 2472
-
(2012)
Expert Opin. Pharmacother.
, vol.13
, pp. 2453-2472
-
-
MacCiò, A.1
Madeddu, C.2
Mantovani, G.3
-
19
-
-
77949765184
-
The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice
-
A. Mittal, S. Bhatnagar, A. Kumar, E. Lach-Trifilieff, S. Wauters, H. Li, D.Y. Makonchuk, D.J. Glass, and A. Kumar The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice J. Cell Biol. 188 2010 833 849
-
(2010)
J. Cell Biol.
, vol.188
, pp. 833-849
-
-
Mittal, A.1
Bhatnagar, S.2
Kumar, A.3
Lach-Trifilieff, E.4
Wauters, S.5
Li, H.6
Makonchuk, D.Y.7
Glass, D.J.8
Kumar, A.9
-
20
-
-
77957338124
-
Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice
-
A. Mittal, S. Bhatnagar, A. Kumar, P.K. Paul, S. Kuang, and A. Kumar Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice Am. J. Pathol. 177 2010 1732 1742
-
(2010)
Am. J. Pathol.
, vol.177
, pp. 1732-1742
-
-
Mittal, A.1
Bhatnagar, S.2
Kumar, A.3
Paul, P.K.4
Kuang, S.5
Kumar, A.6
-
21
-
-
78649853041
-
Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function
-
K.T. Murphy, R. Koopman, T. Naim, B. Leger, J. Trieu, C. Ibebunjo, and G.S. Lynch Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function FASEB J. 24 2010 4433 4442
-
(2010)
FASEB J.
, vol.24
, pp. 4433-4442
-
-
Murphy, K.T.1
Koopman, R.2
Naim, T.3
Leger, B.4
Trieu, J.5
Ibebunjo, C.6
Lynch, G.S.7
-
22
-
-
71649110398
-
Update on emerging drugs for cancer cachexia
-
K.T. Murphy, and G.S. Lynch Update on emerging drugs for cancer cachexia Expert Opin. Emerg. Drugs 14 2009 619 632
-
(2009)
Expert Opin. Emerg. Drugs
, vol.14
, pp. 619-632
-
-
Murphy, K.T.1
Lynch, G.S.2
-
23
-
-
84863434061
-
Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia
-
K.T. Murphy, A. Chee, J. Trieu, T. Naim, and G.S. Lynch Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia Dis. Model. Mech. 5 2012 533 545
-
(2012)
Dis. Model. Mech.
, vol.5
, pp. 533-545
-
-
Murphy, K.T.1
Chee, A.2
Trieu, J.3
Naim, T.4
Lynch, G.S.5
-
24
-
-
77950340105
-
Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics"
-
M. Muscaritoli, S.D. Anker, J. Argilés, Z. Aversa, J.M. Bauer, G. Biolo, Y. Boirie, I. Bosaeus, T. Cederholm, P. Costelli, and et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics" Clin. Nutr. 29 2010 154 159
-
(2010)
Clin. Nutr.
, vol.29
, pp. 154-159
-
-
Muscaritoli, M.1
Anker, S.D.2
Argilés, J.3
Aversa, Z.4
Bauer, J.M.5
Biolo, G.6
Boirie, Y.7
Bosaeus, I.8
Cederholm, T.9
Costelli, P.10
-
25
-
-
0037223197
-
Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death
-
M. Nakayama, K. Ishidoh, Y. Kojima, N. Harada, E. Kominami, K. Okumura, and H. Yagita Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death J. Immunol. 170 2003 341 348
-
(2003)
J. Immunol.
, vol.170
, pp. 341-348
-
-
Nakayama, M.1
Ishidoh, K.2
Kojima, Y.3
Harada, N.4
Kominami, E.5
Okumura, K.6
Yagita, H.7
-
26
-
-
16244391419
-
The role of glucocorticoids in the induction of zinc-alpha2-glycoprotein expression in adipose tissue in cancer cachexia
-
S.T. Russell, and M.J. Tisdale The role of glucocorticoids in the induction of zinc-alpha2-glycoprotein expression in adipose tissue in cancer cachexia Br. J. Cancer 92 2005 876 881
-
(2005)
Br. J. Cancer
, vol.92
, pp. 876-881
-
-
Russell, S.T.1
Tisdale, M.J.2
-
27
-
-
84877697920
-
Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity
-
S. Salzmann, A. Seher, J. Trebing, D. Weisenberger, A. Rosenthal, D. Siegmund, and H. Wajant Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity J. Biol. Chem. 288 2013 13455 13466
-
(2013)
J. Biol. Chem.
, vol.288
, pp. 13455-13466
-
-
Salzmann, S.1
Seher, A.2
Trebing, J.3
Weisenberger, D.4
Rosenthal, A.5
Siegmund, D.6
Wajant, H.7
-
28
-
-
0032993566
-
TWEAK can induce cell death via endogenous TNF and TNF receptor 1
-
P. Schneider, R. Schwenzer, E. Haas, F. Mühlenbeck, G. Schubert, P. Scheurich, J. Tschopp, and H. Wajant TWEAK can induce cell death via endogenous TNF and TNF receptor 1 Eur. J. Immunol. 29 1999 1785 1792
-
(1999)
Eur. J. Immunol.
, vol.29
, pp. 1785-1792
-
-
Schneider, P.1
Schwenzer, R.2
Haas, E.3
Mühlenbeck, F.4
Schubert, G.5
Scheurich, P.6
Tschopp, J.7
Wajant, H.8
-
29
-
-
84899062776
-
The TWEAK-Fn14 pathway: A potent regulator of skeletal muscle biology in health and disease
-
M.M. Tajrishi, T.S. Zheng, L.C. Burkly, and A. Kumar The TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and disease Cytokine Growth Factor Rev. 25 2014 215 225
-
(2014)
Cytokine Growth Factor Rev.
, vol.25
, pp. 215-225
-
-
Tajrishi, M.M.1
Zheng, T.S.2
Burkly, L.C.3
Kumar, A.4
-
30
-
-
67649982995
-
Mechanisms of cancer cachexia
-
M.J. Tisdale Mechanisms of cancer cachexia Physiol. Rev. 89 2009 381 410
-
(2009)
Physiol. Rev.
, vol.89
, pp. 381-410
-
-
Tisdale, M.J.1
-
31
-
-
36048999753
-
IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis
-
E. Varfolomeev, J.W. Blankenship, S.M. Wayson, A.V. Fedorova, N. Kayagaki, P. Garg, K. Zobel, J.N. Dynek, L.O. Elliott, H.J. Wallweber, and et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis Cell 131 2007 669 681
-
(2007)
Cell
, vol.131
, pp. 669-681
-
-
Varfolomeev, E.1
Blankenship, J.W.2
Wayson, S.M.3
Fedorova, A.V.4
Kayagaki, N.5
Garg, P.6
Zobel, K.7
Dynek, J.N.8
Elliott, L.O.9
Wallweber, H.J.10
-
32
-
-
84858627919
-
Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors
-
E. Varfolomeev, T. Goncharov, H. Maecker, K. Zobel, L.G. Kömüves, K. Deshayes, and D. Vucic Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors Sci. Signal. 5 2012 ra22
-
(2012)
Sci. Signal.
, vol.5
, pp. ra22
-
-
Varfolomeev, E.1
Goncharov, T.2
Maecker, H.3
Zobel, K.4
Kömüves, L.G.5
Deshayes, K.6
Vucic, D.7
-
33
-
-
33749621818
-
TWEAK shall inherit the earth
-
J.E. Vince, and J. Silke TWEAK shall inherit the earth Cell Death Differ. 13 2006 1842 1844
-
(2006)
Cell Death Differ.
, vol.13
, pp. 1842-1844
-
-
Vince, J.E.1
Silke, J.2
-
34
-
-
36148954336
-
IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis
-
J.E. Vince, W.W. Wong, N. Khan, R. Feltham, D. Chau, A.U. Ahmed, C.A. Benetatos, S.K. Chunduru, S.M. Condon, M. McKinlay, and et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis Cell 131 2007 682 693
-
(2007)
Cell
, vol.131
, pp. 682-693
-
-
Vince, J.E.1
Wong, W.W.2
Khan, N.3
Feltham, R.4
Chau, D.5
Ahmed, A.U.6
Benetatos, C.A.7
Chunduru, S.K.8
Condon, S.M.9
McKinlay, M.10
-
35
-
-
47549097367
-
TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha
-
J.E. Vince, D. Chau, B. Callus, W.W. Wong, C.J. Hawkins, P. Schneider, M. McKinlay, C.A. Benetatos, S.M. Condon, S.K. Chunduru, and et al. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha J. Cell Biol. 182 2008 171 184
-
(2008)
J. Cell Biol.
, vol.182
, pp. 171-184
-
-
Vince, J.E.1
Chau, D.2
Callus, B.3
Wong, W.W.4
Hawkins, C.J.5
Schneider, P.6
McKinlay, M.7
Benetatos, C.A.8
Condon, S.M.9
Chunduru, S.K.10
-
36
-
-
84879155722
-
Diagnostic criteria of cancer cachexia: Relation to quality of life, exercise capacity and survival in unselected palliative care patients
-
O. Wallengren, K. Lundholm, and I. Bosaeus Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients Support. Care Cancer 21 2013 1569 1577
-
(2013)
Support. Care Cancer
, vol.21
, pp. 1569-1577
-
-
Wallengren, O.1
Lundholm, K.2
Bosaeus, I.3
-
37
-
-
0034032155
-
The symptoms of advanced cancer: Relationship to age, gender, and performance status in 1,000 patients
-
D. Walsh, S. Donnelly, and L. Rybicki The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients Support. Care Cancer 8 2000 175 179
-
(2000)
Support. Care Cancer
, vol.8
, pp. 175-179
-
-
Walsh, D.1
Donnelly, S.2
Rybicki, L.3
-
38
-
-
0000654568
-
The immediate cause of death in cancer
-
S. Warren The immediate cause of death in cancer Am. J. Med. Sci. 184 1932 610 613
-
(1932)
Am. J. Med. Sci.
, vol.184
, pp. 610-613
-
-
Warren, S.1
-
39
-
-
18244380611
-
A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis
-
S.R. Wiley, L. Cassiano, T. Lofton, T. Davis-Smith, J.A. Winkles, V. Lindner, H. Liu, T.O. Daniel, C.A. Smith, and W.C. Fanslow A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis Immunity 15 2001 837 846
-
(2001)
Immunity
, vol.15
, pp. 837-846
-
-
Wiley, S.R.1
Cassiano, L.2
Lofton, T.3
Davis-Smith, T.4
Winkles, J.A.5
Lindner, V.6
Liu, H.7
Daniel, T.O.8
Smith, C.A.9
Fanslow, W.C.10
-
40
-
-
42949160019
-
The TWEAK-Fn14 cytokine-receptor axis: Discovery, biology and therapeutic targeting
-
J.A. Winkles The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting Nat. Rev. Drug Discov. 7 2008 411 425
-
(2008)
Nat. Rev. Drug Discov.
, vol.7
, pp. 411-425
-
-
Winkles, J.A.1
-
41
-
-
77955642517
-
Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival
-
X. Zhou, J.L. Wang, J. Lu, Y. Song, K.S. Kwak, Q. Jiao, R. Rosenfeld, Q. Chen, T. Boone, W.S. Simonet, and et al. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival Cell 142 2010 531 543
-
(2010)
Cell
, vol.142
, pp. 531-543
-
-
Zhou, X.1
Wang, J.L.2
Lu, J.3
Song, Y.4
Kwak, K.S.5
Jiao, Q.6
Rosenfeld, R.7
Chen, Q.8
Boone, T.9
Simonet, W.S.10
|